A
Arcutis Biotherapeutics, Inc.
ARQT · NASDAQ · Healthcare · 3.3B
Closing price
$26.58
+8.53% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
17.8×
Enterprise value / EBITDAEV/EBITDA
1348.9×
Free cash flow yieldFCF yield
-0.2%
Return on equityROE
-8.5%
Operating margin
-3.3%
Net debt / EBITDAbalance-sheet strength
-14.8×
Interest coverage
-1.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.